Need professional-grade analysis? Visit stockanalysis.com
$31.49B
50.00
2,652
0.53%
Joinn Laboratories China Co Ltd (6127) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at HKD21.98, down 4.60% from the previous close.
Over the past year, 6127 has traded between a low of HKD9.62 and a high of HKD27.95. The stock has gained 119.3% over this period. It is currently 21.4% below its 52-week high.
Joinn Laboratories China Co Ltd has a market capitalization of $31.49B, with a price-to-earnings ratio of 50.00 and a dividend yield of 0.53%.
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment engages in the design, production, breeding, and sale of research models, including non-human primates and rodents. The company also offers cell-based assay (CBA) services. In addition, it offers drug quality research and testing services for protein drugs, vaccines, gene and cell therapy products, and provides customized solutions for early-stage drug discovery, screening, and mechanism research. Joinn Laboratories(China)Co.,Ltd. was incorporated in 1995 and is headquartered in Beijing, China.
Side-by-side comparison against top Healthcare peers.